Póster de congreso
Página de inicio de la colección
Listar por
Elementos de la colección (clasificados por Fecha de envío en orden Descendente): 21 a 40 de 1354
| Título | Autor/a | Año | Tipo | Vista previa |
|---|---|---|---|---|
| Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU | Chaparro, M.; Barreiro-de Acosta, M.; Benítez, J.; Cabriada,J.; Casanova, M., et al. | 2019 | Póster de congresos | |
| Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery | Baldan-Martin, M.; Azkargorta,M.; Iloro,I.; Ortega Moreno,L.; Aldars Garcia,L., et al. | 2022 | Póster de congresos | |
| Prediction of severe Crohn’s disease in a Spanish cohort | Bastida, G.; Merino, O.; Aguas, M.; Barreiro, M.; Zabana, Y., et al. | 2010 | Póster de congresos | |
| Extracción quirúrgica endovenosa de parásitos adultos de dirofilaria immitis en un gato | García Rodríguez, Sara Nieves ; Matos Rivero, Jorge Isidoro ; García Guasch,Laín; Santana González, Alexis José ; Mohr Peraza, Eva , et al. | 2025 | Póster de congresos | |
| The risk of severe Crohn's disease: validation of a clinical prediction rule | Bastida, Guillermo; Merino, Olga; Aguas, Mariam; Barreiro, Manuel; Zabana, Yamile, et al. | 2009 | Póster de congresos | |
| Long-term results of Adalimumab treatment in subjects with moderately to severely active fistulizing Crohn’s Disease who failed response or showed intolerance to infliximab | Gomollón, Fernando; Hinojosa, Janet; Nos, Pilar; Penate, M.; Ceballos Santos, Daniel Sebastián , et al. | 2007 | Póster de congresos | |
| Independencia del paciente geriátrico ingresado en un Servicio de Digestivo | Ortega, V.; Ceballos Santos, Daniel Sebastián ; Chang Lee W.; Ortiz, E.; Rodríguez San Román, J.L., et al. | 2006 | Póster de congresos | |
| Tiempo de latencia de aparición de nuevos pólipos | Ceballos Santos, Daniel Sebastián ; Marchena Gómez, J.; Mathias Gutiérrez, M. P.; Velázquez González, B.; Alonso Rivera, J. M., et al. | 2005 | Ponencia | |
| Effect of Zn Additions on the Corrosion Resistance of Mg in Physiological Conditions | Mirza Rosca, Julia Claudia ; Voiculescu, Ionelia ; Geanta, Victoras ; Sanchez Sosa, Francisco Miguel | 2025 | Póster de congresos | |
| El yacimiento de Buenavista, un asentamiento fenicio-púnico en Lanzarote (Islas Canarias) (circa 960-360 a.n.e.) | Atoche Peña, Pablo ; Ramírez Rodríguez,María Ángeles | 2009 | Póster de congresos | |
| Comparative efficacy and safety of upadacitinib versus ustekinumab as induction therapy in patients with moderately to severely active ulcerative colitis: A matching-adjusted indirect comparison | Reinisch, W.; Panaccione,R.; Duijvestein,M.; Ceballos Santos, Daniel Sebastián | 2023 | Póster de congresos | |
| Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease | Soleto,I.; Baldan,M.; Ramírez, C.; Orejudo, M.; García, S., et al. | 2023 | Póster de congresos | |
| Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach | Baldan-Martin, M.; Azkargorta, M.; Lloro, I.; Soleto Fernández, I.; Orejudo, M., et al. | 2023 | Póster de congresos | |
| Controversies in the management of anti-TNF therapy in Crohn’s disease patients. A Delphi consensus | Gonzalez Lama, Y.; Ricart, E.; Carpio, D.; Bastida, G.; Ceballos Santos, Daniel Sebastián , et al. | 2023 | Póster de congresos | |
| Feasibility and safety of endoscopic submucosal dissection in inflammatory bowel disease (ESDEUR-IBD): an interim analysis of European retrospective study | García, M.J.; Fraile,M.; Katinios, G.; Gubbiotti, A.; Argyriou, K., et al. | 2025 | Ponencia | |
| Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry | Calafat Sard,M.; Mañosa,M.; Fernández-Clotet,A.; Pasanau,L.; Matallana,V., et al. | 2025 | Póster de congresos | |
| Real-world short and long-term effectiveness of risankizumab in refractory Crohn’s disease: RISANCROHN study from the ENEIDA Registry | Barreiro-de Acosta, M.; Nieto-Garcia, L.; Poncela, M.; Aguas, M.; Martinez Cuevas, C., et al. | 2025 | Póster de congresos | |
| Effectiveness and safety of upadacitinib in ulcerative colitis in clinical practice: results from the U-REAL-UC study from ENEIDA | Chaparro, M.; Hermida, S.; Zabalza San Martín, L.; Tosca Cuquerella, J.; Castro, L. de, et al. | 2025 | Póster de congresos | |
| Real-world efficacy and safety of filgotinib in ulcerative colitis: results from the ENEIDA registry | Rodríguez-Lago, I.; Cudero, L.; Martínez Pascual, C.; Mínguez, A.; Ferreiro-Iglesias, R., et al. | 2025 | Póster de congresos | |
| Real-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA database | Iborra, M.; Botella, B.; Martín-Arranz, M.D.; Ceballos Santos, Daniel Sebastián | 2025 | Póster de congresos |
Elementos de la colección (clasificados por Fecha de envío en orden Descendente): 21 a 40 de 1354